date,title,source
Nov-14-18,Trillium Therapeutics Reports Third Quarter 2018 Financial and Operating Results,GlobeNewswire
Dec-03-18,Trillium Therapeutics Provides Update on its Intratumoral TTI-621 Program at the American Society of Hematology 60th Annual Meeting,GlobeNewswire
Feb-21-19,Trillium Announces Proposed Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units,GlobeNewswire
